Stay updated on Venetoclax in Myeloma with Bortezomib: Clinical Trial
Sign up to get notified when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.

Latest updates to the Venetoclax in Myeloma with Bortezomib: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.3.2 was added, replacing v3.3.1. This appears to be a backend version update with no visible changes to study records or navigation.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page shows a system update: Revision: v3.3.1 was added and Revision: v3.2.0 was removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe notice about government funding and site operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check44 days agoChange DetectedThe old and new screenshots show a cosmetic update to the Record History page without changes to the actual study data or version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check72 days agoChange DetectedUpgrade to v3.2.0 with a new government-operating status notice and funding caveat; removes v3.1.0. This introduces current-operational caveats and directs users to status pages.SummaryDifference10%

- Check79 days agoChange Detected- Version updated from v3.0.2 to v3.1.0. This indicates a new release/build; no other content changes are indicated.SummaryDifference0.3%

Stay in the know with updates to Venetoclax in Myeloma with Bortezomib: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.